Calidi Biotherapeutics, Inc. CLDI Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001641172-25-010317
cik 1855485
name CALIDI BIOTHERAPEUTICS, INC.
sic 2836
countryba US
stprba CA
cityba SAN DIEGO
zipba 92121
bas1 4475 EXECUTIVE DRIVE
bas2 SUITE 200
baph 858-794-9600
countryma US
stprma CA
cityma SAN DIEGO
zipma 92121
mas1 4475 EXECUTIVE DRIVE
mas2 SUITE 200
countryinc US
stprinc DE
ein 862967193
former FIRST LIGHT ACQUISITION GROUP, INC.
changed 20210406
afs 4-NON
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250514
accepted 2025-05-14 16:46:00.0
prevrpt 0
detail 1
instance form10-q_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001641172-25-010317 20241231 Accounts Payable Current 2000.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001641172-25-010317 20250331 Accrued Liabilities Current 36000.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Financing Fees -327000.0000 USD 1 0001641172-25-010317 Equity Components= Parent;
0001641172-25-010317 20250331 Assets 15064000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Cash 10561000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 9809000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -806000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20241231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Common Stock Shares Authorized 330000000.0000 shares 0 us-gaap/2024
0001641172-25-010317 20241231 Common Stock Shares Issued 20760214.0000 shares 0 us-gaap/2024
0001641172-25-010317 20250331 Common Stock Shares Issued 31792580.0000 shares 0 us-gaap/2024
0001641172-25-010317 20241231 Common Stock Shares Outstanding 20760214.0000 shares 0 us-gaap/2024
0001641172-25-010317 20250331 Common Stock Value 3000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Earnings Per Share Basic -2.0300 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Increase Decrease In Accrued Liabilities And Other Operating Liabilities -1687000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Increase Decrease In Operating Lease Liability -279000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants For March Registered Direct Offering And Concurrent Private Placement Net Of Financing Costs USD 1 0001641172-25-010317 Equity Components= Retained Earnings;
0001641172-25-010317 20241231 Minority Interest 434000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Net Cash Provided By Used In Financing Activities 8108000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Net Income Loss -5062000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-010317 20250331 Net Income Loss -4986000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20250331 Operating Expenses 5062000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20241231 Operating Lease Liability Noncurrent 1845000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Operating Lease Right Of Use Asset Amortization Expense 272000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20240331 Proceeds From Convertible Debt 3000000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Proceeds From Convertible Debt USD 1 us-gaap/2024
0001641172-25-010317 20240331 Repayments Of Notes Payable USD 1 us-gaap/2024
0001641172-25-010317 20250331 Repayments Of Notes Payable 200000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Research And Development Expense 2743000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -8235000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -14573000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1968000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6941000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20240331 Stock Issued During Period Shares Acquisitions 1581.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20250331 Stock Issued During Period Shares New Issues 2682911.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20240331 Stock Issued During Period Value Acquisitions USD 1 us-gaap/2024
0001641172-25-010317 20240331 Stock Issued During Period Value Acquisitions USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20240331 Stock Issued During Period Value Issued For Services 29000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Stock Issued During Period Value Issued For Services 29000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20240331 Stock Issued During Period Value Lieu Of Cash For Commitment Fee 81000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20240331 Stock Issued During Period Value Lieu Of Cash For Commitment Fee USD 1 0001641172-25-010317 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20240731 Stock Issued During Period Value New Issues 2000000.0000 USD 0 us-gaap/2024 Title Of Individual= Board Of Directors;
0001641172-25-010317 20250331 Stock Issued During Period Value New Issues 2754000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20250331 Stock Issued During Period Value New Issues USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -28000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Financing Fees USD 1 0001641172-25-010317 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 888000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 888000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Warrant Issued USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Warrant Issued 158000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 970000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Commitments And Contingencies USD 0 us-gaap/2024
0001641172-25-010317 20250331 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Discount On Convertible Note Payable USD 1 0001641172-25-010317
0001641172-25-010317 20250331 Income Tax Expense Benefit 3000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Income Tax Expense Benefit 3000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-010317 20250331 Increase Decrease In Accounts Payable -752000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants For March Registered Direct Offering And Concurrent Private Placement Net Of Financing Costs 3423000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants For March Registered Direct Offering And Concurrent Private Placement Net Of Financing Costs USD 1 0001641172-25-010317 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants For March Registered Direct Offering And Concurrent Private Placement Net Of Financing Costs 3423000.0000 USD 1 0001641172-25-010317 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants Through January Confidentially Marketed Public Offering Net Of Financing Costs 3606000.0000 USD 1 0001641172-25-010317 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants Through January Confidentially Marketed Public Offering Net Of Financing Costs 1000.0000 USD 1 0001641172-25-010317 Equity Components= Common Stock;
0001641172-25-010317 20241231 Liabilities Current 9496000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20241231 Loans Payable Current 223000.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001641172-25-010317 20250331 Minority Interest 358000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20250331 Net Income Loss -4986000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20240331 Net Income Loss Attributable To Noncontrolling Interest USD 1 us-gaap/2024
0001641172-25-010317 20250331 Net Income Loss Available To Common Stockholders Basic -4986000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Nonoperating Income Expense -469000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20241231 Operating Lease Liability Current 1204000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20241231 Operating Lease Right Of Use Asset 2934000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20240331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent 58000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20240331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20250331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20240331 Other Nonoperating Income Expense -17000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Payments Of Financing Costs 301000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20241231 Retained Earnings Accumulated Deficit -121715000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Share Based Compensation 607000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -99572000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20240331 Stock Issued During Period Shares Issued For Services 5000000.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20240331 Stock Issued During Period Shares Issued For Services 13875.0000 shares 1 us-gaap/2024 Type Of Arrangement= Term Note Agreement;
0001641172-25-010317 20240331 Stock Issued During Period Shares Lieu Of Cash For Commitment Fee 13875000.0000 shares 1 0001641172-25-010317 Equity Components= Common Stock;
0001641172-25-010317 20240331 Stock Issued During Period Value Acquisitions USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20250331 Stock Issued During Period Value New Issues USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20250331 Stock Issued During Period Value Restricted Stock Award Gross USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20241231 Accrued Liabilities Current 480000.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001641172-25-010317 20250331 Accounts Payable Current 7000.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 888000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Warrant Issued 158000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Warrant Issued 158000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20250331 Assets Current 11489000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Common Stock Shares Outstanding 31792580.0000 shares 0 us-gaap/2024
0001641172-25-010317 20250331 Comprehensive Income Net Of Tax -4984000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest -76000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Discount On Convertible Note Payable 149000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20240331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 17000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -5059000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants For March Registered Direct Offering And Concurrent Private Placement Net Of Financing Costs USD 1 0001641172-25-010317 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants For March Registered Direct Offering And Concurrent Private Placement Net Of Financing Costs Shares 3325000.0000 shares 1 0001641172-25-010317 Equity Components= Common Stock;
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants Through January Confidentially Marketed Public Offering Net Of Financing Costs 3607000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20240331 Issuance Of Warrants For Legal Settlement 158000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20250331 Issuance Of Warrants For Legal Settlement USD 1 0001641172-25-010317
0001641172-25-010317 20240331 Net Cash Provided By Used In Investing Activities -5000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Net Cash Provided By Used In Operating Activities -7131000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20250331 Operating Lease Liability Current 1252000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Operating Lease Right Of Use Asset 2636000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Other Assets Noncurrent 144000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent 2000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20240331 Profit Loss -7225000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Property Plant And Equipment Net 795000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Repayments Of Debt And Capital Lease Obligations 17000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Share Based Compensation 888000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -8235000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 11000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 123275000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 133665000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20240331 Stock Issued During Period Value Acquisitions USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20240331 Stock Issued During Period Value Acquisitions USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20240331 Stock Issued During Period Value Issued For Services USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20240331 Stock Issued During Period Value Lieu Of Cash For Commitment Fee USD 1 0001641172-25-010317 Equity Components= Retained Earnings;
0001641172-25-010317 20250131 Stock Issued During Period Value New Issues 5100000.0000 USD 0 us-gaap/2024 Type Of Arrangement= Market Offering Agreement;
0001641172-25-010317 20250331 Stock Issued During Period Value New Issues 5000000.0000 USD 1 us-gaap/2024 Type Of Arrangement= Term Note Agreement;
0001641172-25-010317 20250331 Stock Issued During Period Value Restricted Stock Award Gross USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20240331 Weighted Average Number Of Diluted Shares Outstanding 3555.0000 shares 1 us-gaap/2024
0001641172-25-010317 20241231 Accounts Payable Current 2072000.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Nonrelated Party;
0001641172-25-010317 20241231 Accrued Liabilities Current 1858000.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Nonrelated Party;
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 607000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 607000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Warrant Issued USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Warrant Issued USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20240331 Amortization Of Debt Discount Premium 16000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Cash 1143000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Change In Fair Value Of Other Liabilities And Derivatives -35000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20250331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -5060000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Earnings Per Share Basic -0.1800 USD 1 us-gaap/2024
0001641172-25-010317 20241231 Finance Lease Liability Current 66000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Finance Lease Liability Current 69000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Grant Income USD 1 0001641172-25-010317
0001641172-25-010317 20250331 Grant Income 50000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20240331 Income Tax Expense Benefit 4000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Increase Decrease In Accounts Payable 968000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Interest Expense Nonoperating 98000.0000 USD 1 us-gaap/2024 Related Party Transactions By Related Party= Nonrelated Party;
0001641172-25-010317 20240331 Interest Expense Nonoperating 155000.0000 USD 1 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001641172-25-010317 20250331 Interest Expense Nonoperating 38000.0000 USD 1 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001641172-25-010317 20250331 Issuance Of Common Stock For Legal Settlement USD 1 0001641172-25-010317
0001641172-25-010317 20240331 Issuance Of Common Stock In Lieu Of Cash For Sepa Commitment Fee 81000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20240331 Net Income Loss -7225000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20250331 Operating Income Loss -5062000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent 58000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Payment Of Interest On Loan Payable 2000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20240331 Proceeds From Registered Direct Offering USD 1 0001641172-25-010317
0001641172-25-010317 20240131 Proceeds From Related Party Debt 200000.0000 USD 0 us-gaap/2024 Debt Instrument= Two Thousand Twenty Four Bridge Loan;
0001641172-25-010317 20250331 Proceeds From Related Party Debt USD 1 us-gaap/2024
0001641172-25-010317 20250331 Promissory Note 600000.0000 USD 0 0001641172-25-010317
0001641172-25-010317 20240331 Repayments Of Debt And Capital Lease Obligations 23000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Repayments Of Related Party Debt USD 1 us-gaap/2024
0001641172-25-010317 20250331 Retained Earnings Accumulated Deficit -126701000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20231231 Shares Outstanding 3552223.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20241231 Stockholders Equity 1534000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 92212000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -106797000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -26000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20240731 Stock Issued During Period Shares New Issues 7500000.0000 shares 0 us-gaap/2024 Title Of Individual= Board Of Directors;
0001641172-25-010317 20250331 Stock Issued During Period Shares New Issues 2728000.0000 shares 0 us-gaap/2024 Equity Components= Pre Funded Warrants; Type Of Arrangement= Securities Purchase Agreement;
0001641172-25-010317 20250331 Stock Issued During Period Shares New Issues 6053000.0000 shares 0 us-gaap/2024 Equity Components= Warrant; Type Of Arrangement= Securities Purchase Agreement;
0001641172-25-010317 20250331 Stock Issued During Period Shares New Issues 2682911.0000 shares 1 us-gaap/2024
0001641172-25-010317 20240331 Stock Issued During Period Value Issued For Services USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20240331 Stock Issued During Period Value Lieu Of Cash For Commitment Fee USD 1 0001641172-25-010317 Equity Components= Common Stock;
0001641172-25-010317 20240731 Stock Issued During Period Value New Issues 1000000.0000 USD 0 us-gaap/2024 Equity Components= Warrant;
0001641172-25-010317 20250331 Accrued Liabilities Current 1732000.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Nonrelated Party;
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Financing Fees -327000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20241231 Assets Current 10227000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2167000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest USD 1 us-gaap/2024
0001641172-25-010317 20240331 Depreciation 102000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-010317 20250331 Depreciation 91000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-010317 20250331 Income Taxes Paid Net 3000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Increase Decrease In Accrued Liabilities And Other Operating Liabilities -388000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants For March Registered Direct Offering And Concurrent Private Placement Net Of Financing Costs 3423000.0000 USD 1 0001641172-25-010317 Equity Components= Parent;
0001641172-25-010317 20241231 Liabilities 12214000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20250331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20240331 Net Income Loss Available To Common Stockholders Basic -7225000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Nonoperating Income Expense 3000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 2000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Other Liabilities Current USD 0 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001641172-25-010317 20250331 Payment Of Interest On Loan Payable USD 1 0001641172-25-010317
0001641172-25-010317 20240331 Payments Of Financing Costs 162000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Prepaid Expense And Other Assets Current 928000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Proceeds From Registered Direct Offering 3503000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20240331 Proceeds From Related Party Debt 200000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -47000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 91383000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -14573000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -121715000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 7299000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -126701000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20240331 Stock Issued During Period Shares New Issues 5000.0000 shares 1 us-gaap/2024
0001641172-25-010317 20240331 Stock Issued During Period Value Issued For Services 29000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20240331 Stock Issued During Period Value Lieu Of Cash For Commitment Fee USD 1 0001641172-25-010317 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20240331 Stock Issued During Period Value Lieu Of Cash For Commitment Fee 81000.0000 USD 1 0001641172-25-010317 Equity Components= Parent;
0001641172-25-010317 20250331 Stock Issued During Period Value Restricted Stock Award Gross USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20250331 Stock Issued During Period Value Restricted Stock Award Gross USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20241231 Term Notes Payable Current 251000.0000 USD 0 0001641172-25-010317 Related Party Transactions By Related Party= Nonrelated Party;
0001641172-25-010317 20250331 Weighted Average Number Of Diluted Shares Outstanding 27086.0000 shares 1 us-gaap/2024
0001641172-25-010317 20250331 Weighted Average Number Of Shares Outstanding Basic 27086.0000 shares 1 us-gaap/2024
0001641172-25-010317 20250331 Accounts Payable Current 1198000.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Nonrelated Party;
0001641172-25-010317 20250331 Additional Paid In Capital 133665000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Financing Fees USD 1 0001641172-25-010317 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Warrant Issued USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20241231 Cash 9591000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Change In Fair Value Of Other Liabilities And Derivatives 199000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20250331 Change In Fair Value Of Other Liabilities And Derivatives -32000.0000 USD 1 0001641172-25-010317 Related Party Transactions By Related Party= Nonrelated Party;
0001641172-25-010317 20250331 Common Stock Shares Outstanding 1800000.0000 shares 0 us-gaap/2024 Class Of Stock= Nonvoting Common Stock;
0001641172-25-010317 20241231 Common Stock Value 2000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -7167000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Depreciation 91000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Earnings Per Share Diluted -2.0300 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents USD 1 us-gaap/2024
0001641172-25-010317 20250331 Finance Lease Liability Noncurrent 129000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Financing Fees 80000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20240331 Interest Paid Net 24000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Interest Paid Net 639000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants For March Registered Direct Offering And Concurrent Private Placement Net Of Financing Costs USD 1 0001641172-25-010317 Equity Components= Common Stock;
0001641172-25-010317 20240331 Issuance Of Common Stock For Legal Settlement 1500000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20240331 Issuance Of Common Stock In Lieu Of Cash For Services 29000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20250331 Net Cash Provided By Used In Investing Activities -7000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Net Income Loss -7225000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20250331 Net Income Loss -5062000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20250331 Net Income Loss -76000.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20250331 Operating Lease Liability Noncurrent 1523000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent 58000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20250331 Other Nonoperating Income Expense -10000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Proceeds From April Public Offering 6573000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20250331 Profit Loss -5062000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20241231 Promissory Note 600000.0000 USD 0 0001641172-25-010317
0001641172-25-010317 20240331 Repayment Of Principal On Related Party Bridge Loan Payable USD 1 0001641172-25-010317
0001641172-25-010317 20250331 Repayment Of Principal On Related Party Bridge Loan Payable 200000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20241231 Shares Outstanding 20760214.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20250331 Shares Outstanding 31792580.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -28000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 434000.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1534000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 358000.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20241231 Stock Issued During Period Shares New Issues 5000000.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Type Of Arrangement= Placement Agency Agreement;
0001641172-25-010317 20240331 Stock Issued During Period Value Acquisitions USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20240331 Stock Issued During Period Value Issued For Services USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20240331 Stock Issued During Period Value Issued For Services USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20240331 Stock Issued During Period Value Lieu Of Cash For Commitment Fee 81000.0000 USD 1 0001641172-25-010317 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20250331 Stock Issued During Period Value New Issues 2754000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Stock Issued During Period Value Restricted Stock Award Gross USD 1 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20250331 Term Notes Payable Current USD 0 0001641172-25-010317 Related Party Transactions By Related Party= Nonrelated Party;
0001641172-25-010317 20240331 Weighted Average Number Of Shares Outstanding Basic 3555.0000 shares 1 us-gaap/2024
0001641172-25-010317 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1361000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax -26000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20241231 Additional Paid In Capital 123275000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Financing Fees USD 1 0001641172-25-010317 Equity Components= Common Stock;
0001641172-25-010317 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20250331 Amortization Of Debt Discount Premium USD 1 us-gaap/2024
0001641172-25-010317 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 10779000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20241231 Common Stock Shares Authorized 330000000.0000 shares 0 us-gaap/2024
0001641172-25-010317 20250331 Common Stock Shares Authorized 312000000.0000 shares 0 us-gaap/2024 Class Of Stock= Voting Common Stock;
0001641172-25-010317 20240331 Comprehensive Income Net Of Tax -7167000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20241231 Finance Lease Liability Noncurrent 145000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Financing Fees 248000.0000 USD 1 0001641172-25-010317
0001641172-25-010317 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -7221000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Income Tax Expense Benefit 4000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-010317 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets 317000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Interest Expense Nonoperating 34000.0000 USD 1 us-gaap/2024 Related Party Transactions By Related Party= Nonrelated Party;
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants Through January Confidentially Marketed Public Offering Net Of Financing Costs USD 1 0001641172-25-010317 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants Through January Confidentially Marketed Public Offering Net Of Financing Costs USD 1 0001641172-25-010317 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20250331 Issuance Of Common Stock In Lieu Of Cash For Services USD 1 0001641172-25-010317
0001641172-25-010317 20241231 Liabilities And Stockholders Equity 14182000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Liabilities And Stockholders Equity 15064000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Loans Payable Current USD 0 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001641172-25-010317 20240331 Net Cash Provided By Used In Financing Activities 3013000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Net Income Loss -7225000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Operating Expenses 6752000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Operating Income Loss -6752000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 58000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20241231 Prepaid Expense And Other Assets Current 636000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Proceeds From April Public Offering USD 1 0001641172-25-010317
0001641172-25-010317 20250331 Related Party Warrant Liability 6000.0000 USD 0 0001641172-25-010317
0001641172-25-010317 20250331 Repayments Of Related Party Debt 1250000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Research And Development Expense 2425000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20250331 Stock Issued During Period Shares New Issues 3325000.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Type Of Arrangement= Securities Purchase Agreement;
0001641172-25-010317 20250331 Stock Issued During Period Shares Restricted Stock Award Gross 24455.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20241231 Warrant Liability 119000.0000 USD 0 0001641172-25-010317
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Financing Fees -327000.0000 USD 1 0001641172-25-010317 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Financing Fees USD 1 0001641172-25-010317 Equity Components= Retained Earnings;
0001641172-25-010317 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 607000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20241231 Assets 14182000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Change In Fair Value Of Other Liabilities And Derivatives 198000.0000 USD 1 0001641172-25-010317 Related Party Transactions By Related Party= Nonrelated Party;
0001641172-25-010317 20241231 Related Party Warrant Liability 9000.0000 USD 0 0001641172-25-010317
0001641172-25-010317 20240331 Change In Fair Value Of Other Liabilities And Derivatives 1000.0000 USD 1 0001641172-25-010317 Related Party Transactions By Related Party= Related Party;
0001641172-25-010317 20250331 Change In Fair Value Of Other Liabilities And Derivatives -3000.0000 USD 1 0001641172-25-010317 Related Party Transactions By Related Party= Related Party;
0001641172-25-010317 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0001641172-25-010317 20240630 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Common Stock Shares Authorized 18000000.0000 shares 0 us-gaap/2024 Class Of Stock= Nonvoting Common Stock;
0001641172-25-010317 20240331 Depreciation 102000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Earnings Per Share Diluted -0.1800 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Income Taxes Paid Net 2000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Increase Decrease In Operating Lease Liability -238000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets -1575000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants Through January Confidentially Marketed Public Offering Net Of Financing Costs 3607000.0000 USD 1 0001641172-25-010317 Equity Components= Parent;
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants Through January Confidentially Marketed Public Offering Net Of Financing Costs USD 1 0001641172-25-010317 Equity Components= Retained Earnings;
0001641172-25-010317 20250331 Issuance Of Common Stock And Warrants Through January Confidentially Marketed Public Offering Net Of Financing Costs Shares 5000000.0000 shares 1 0001641172-25-010317 Equity Components= Common Stock;
0001641172-25-010317 20250331 Issuance Of Common Stock In Lieu Of Cash For Sepa Commitment Fee USD 1 0001641172-25-010317
0001641172-25-010317 20250331 Liabilities 7765000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Liabilities Current 5426000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Net Cash Provided By Used In Operating Activities -3831000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Net Income Loss -7225000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0001641172-25-010317 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20240331 Net Income Loss USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20250331 Net Income Loss Attributable To Noncontrolling Interest -76000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Operating Lease Right Of Use Asset Amortization Expense 303000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20241231 Other Assets Noncurrent 152000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20240331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20250331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent 2000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent 2000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001641172-25-010317 20250331 Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001641172-25-010317 20241231 Other Liabilities Current 638000.0000 USD 0 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001641172-25-010317 20240331 Payments To Acquire Machinery And Equipment 5000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Payments To Acquire Machinery And Equipment 7000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20241231 Property Plant And Equipment Net 869000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20240331 Selling General And Administrative Expense 4009000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20250331 Selling General And Administrative Expense 2637000.0000 USD 1 us-gaap/2024
0001641172-25-010317 20240331 Shares Outstanding 3572679.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20250331 Stockholders Equity 6941000.0000 USD 0 us-gaap/2024
0001641172-25-010317 20250331 Stock Issued During Period Shares Issued For Services 24455.0000 shares 1 us-gaap/2024 Award Type= Restricted Stock Units R S U; Type Of Arrangement= Term Note Agreement;
0001641172-25-010317 20250331 Stock Issued During Period Shares Issued For Services 3325000.0000 shares 1 us-gaap/2024 Subsidiary Sale Of Stock= I P O; Type Of Arrangement= Term Note Agreement;
0001641172-25-010317 20241031 Stock Issued During Period Shares New Issues 4437869.0000 shares 0 us-gaap/2024 Equity Components= Common Stock; Type Of Arrangement= Placement Agency Agreement;
0001641172-25-010317 20240331 Stock Issued During Period Value Acquisitions USD 1 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20250331 Stock Issued During Period Value New Issues USD 1 us-gaap/2024 Equity Components= Common Stock;
0001641172-25-010317 20250331 Stock Issued During Period Value New Issues USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001641172-25-010317 20250331 Stock Issued During Period Value New Issues 2754000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001641172-25-010317 20250331 Stock Issued During Period Value Restricted Stock Award Gross USD 1 us-gaap/2024
0001641172-25-010317 20250331 Stock Issued During Period Value Restricted Stock Award Gross USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001641172-25-010317 20241231 Term Notes Payable Current 2702000.0000 USD 0 0001641172-25-010317 Related Party Transactions By Related Party= Related Party;
0001641172-25-010317 20250331 Term Notes Payable Current 1132000.0000 USD 0 0001641172-25-010317 Related Party Transactions By Related Party= Related Party;
0001641172-25-010317 20250331 Warrant Liability 81000.0000 USD 0 0001641172-25-010317

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary I C Equity, Including Portion Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.
Amortization Of Debt Discount Premium us-gaap/2024 0 0 monetary D D Amortization of Debt Discount (Premium) Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Operating Lease Liability Current us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Adjustments To Additional Paid In Capital Warrant Issued us-gaap/2024 0 0 monetary D C Adjustments to Additional Paid in Capital, Warrant Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.
Stock Issued During Period Shares Restricted Stock Award Gross us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Restricted Stock Award, Gross Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Issuance Of Common Stock And Warrants Through January Confidentially Marketed Public Offering Net Of Financing Costs 0001641172-25-010317 1 0 monetary D C Issuance of common stock and warrants through January Confidentially Marketed Public Offering, net of financing costs Issuance of common stock and warrants through january confidentially marketed public offering net of financing costs
Repayment Of Principal On Related Party Bridge Loan Payable 0001641172-25-010317 1 0 monetary D C Repayment of principal on related party bridge loan payable Repayment of principal on related party bridge loan payable.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D D Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Net Income Loss Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D D Net Income (Loss) Attributable to Noncontrolling Interest Amount of Net Income (Loss) attributable to noncontrolling interest.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Stock Issued During Period Shares Issued For Services us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Issued for Services Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Finance Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Finance Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Issuance Of Common Stock In Lieu Of Cash For Services 0001641172-25-010317 1 0 monetary D C IssuanceOfCommonStockInLieuOfCashForServices Issuance of common stock in lieu of cash for services
Warrant Liability 0001641172-25-010317 1 0 monetary I C Warrant liability Warrant liability
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Cash us-gaap/2024 0 0 monetary I D Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Discount On Convertible Note Payable 0001641172-25-010317 1 0 monetary D C Discount on convertible note payable Discount on convertible note payable.
Issuance Of Common Stock And Warrants Through January Confidentially Marketed Public Offering Net Of Financing Costs Shares 0001641172-25-010317 1 0 shares D Issuance of common stock and warrants through January Confidentially Marketed Public Offering, net of financing costs, shares Issuance of common stock and warrants through january confidentially marketed public offering net of financing costs shares
Issuance Of Common Stock For Legal Settlement 0001641172-25-010317 1 0 monetary D C Issuance of convertible note for legal settlement Issuance of common stock for legal settlement.
Stock Issued During Period Value Lieu Of Cash For Commitment Fee 0001641172-25-010317 1 0 monetary D C Issuance of common stock in lieu of cash for SEPA commitment fee Stock issued during period value lieu of cash for commitment fee.
Term Notes Payable Current 0001641172-25-010317 1 0 monetary I C Related party term notes payable, net of discount, including accrued interest Term notes payable current.
Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Interest Expense Nonoperating us-gaap/2024 0 0 monetary D D Interest Expense, Nonoperating Amount of interest expense classified as nonoperating.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
Proceeds From Convertible Debt us-gaap/2024 0 0 monetary D D Proceeds from Convertible Debt The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
Selling General And Administrative Expense us-gaap/2024 0 0 monetary D D Selling, General and Administrative Expense The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Stock Issued During Period Value Acquisitions us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Acquisitions Value of stock issued pursuant to acquisitions during the period.
Stock Issued During Period Value Issued For Services us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
Issuance Of Common Stock And Warrants For March Registered Direct Offering And Concurrent Private Placement Net Of Financing Costs 0001641172-25-010317 1 0 monetary D C Issuance of common stock and warrants for March Registered Direct Offering and Concurrent Private Placement, net of financing costs Issuance of common stock and warrants for march registered direct offering and concurrent private placement net of financing costs
Proceeds From April Public Offering 0001641172-25-010317 1 0 monetary D D Proceeds from Public Offerings Proceeds from April Public Offering.
Income Taxes Paid Net us-gaap/2024 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Loans Payable Current us-gaap/2024 0 0 monetary I C Loans Payable, Current Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.
Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Other Liabilities Current us-gaap/2024 0 0 monetary I C Other Liabilities, Current Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.
Profit Loss us-gaap/2024 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Repayments Of Related Party Debt us-gaap/2024 0 0 monetary D C Repayments of Related Party Debt The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.
Stock Issued During Period Shares Lieu Of Cash For Commitment Fee 0001641172-25-010317 1 0 shares D Issuance of common stock in lieu of cash for commitment fee, shares Stock issued during period shares lieu of cash for commitment fee.
Increase Decrease In Accrued Liabilities And Other Operating Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Amount of increase (decrease) in accrued expenses, and obligations classified as other.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Repayments Of Notes Payable us-gaap/2024 0 0 monetary D C Repayments of Notes Payable The cash outflow for a borrowing supported by a written promise to pay an obligation.
Financing Fees 0001641172-25-010317 1 0 monetary D C FinancingFees Financing fees
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Stock Issued During Period Shares New Issues us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, New Issues Number of new stock issued during the period.
Adjustments To Additional Paid In Capital Financing Fees 0001641172-25-010317 1 0 monetary D C Financing fees Financing fees.
Issuance Of Warrants For Legal Settlement 0001641172-25-010317 1 0 monetary D C Issuance of warrants for legal settlement [Default Label] Issuance of warrants for legal settlement
Payment Of Interest On Loan Payable 0001641172-25-010317 1 0 monetary D C Payment of interest on loan payable Payment of interest on loan payable
Related Party Warrant Liability 0001641172-25-010317 1 0 monetary I C Related party warrant liability Related party warrant liability.
Accounts Payable Current us-gaap/2024 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Increase Decrease In Accounts Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
Increase Decrease In Operating Lease Liability us-gaap/2024 0 0 monetary D D Increase (Decrease) in Operating Lease Liability Amount of increase (decrease) in obligation for operating lease.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Net Income Loss Available To Common Stockholders Basic us-gaap/2024 0 0 monetary D C Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
Operating Lease Right Of Use Asset Amortization Expense us-gaap/2024 0 0 monetary D D Operating Lease, Right-of-Use Asset, Periodic Reduction Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.
Payments To Acquire Machinery And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Machinery and Equipment The cash outflow for acquisition of machinery and equipment.
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Stock Issued During Period Value Restricted Stock Award Gross us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Restricted Stock Award, Gross Aggregate value of stock related to Restricted Stock Awards issued during the period.
Change In Fair Value Of Other Liabilities And Derivatives 0001641172-25-010317 1 0 monetary D D Change in fair value of other liabilities and derivatives Change in fair value of other liabilities and derivatives.
Issuance Of Common Stock And Warrants For March Registered Direct Offering And Concurrent Private Placement Net Of Financing Costs Shares 0001641172-25-010317 1 0 shares D Issuance of common stock and warrants for March Registered Direct Offering and Concurrent Private Placement, net of financing costs, shares Issuance of common stock and warrants for march registered direct offering and concurrent private placement net of financing costs shares
Finance Lease Liability Current us-gaap/2024 0 0 monetary I C Finance Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Depreciation us-gaap/2024 0 0 monetary D D Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Payments Of Financing Costs us-gaap/2024 0 0 monetary D C Payments of Financing Costs The cash outflow for loan and debt issuance costs.
Proceeds From Related Party Debt us-gaap/2024 0 0 monetary D D Proceeds from Related Party Debt The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.
Stock Issued During Period Value New Issues us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Issuance Of Common Stock In Lieu Of Cash For Sepa Commitment Fee 0001641172-25-010317 1 0 monetary D C IssuanceOfCommonStockInLieuOfCashForSepaCommitmentFee Issuance of common stock in lieu of cash for SEPA commitment fee.
Proceeds From Registered Direct Offering 0001641172-25-010317 1 0 monetary D D Proceeds from Registered Direct Offering Proceeds from registered direct offering
Minority Interest us-gaap/2024 0 0 monetary I C Equity, Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Repayments Of Debt And Capital Lease Obligations us-gaap/2024 0 0 monetary D C Repayments of Debt and Lease Obligation Amount of cash outflow for short-term and long-term debt and lease obligation.
Grant Income 0001641172-25-010317 1 0 monetary D C Grant income Grant income.
Stock Issued During Period Shares Acquisitions us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Acquisitions Number of shares of stock issued during the period pursuant to acquisitions.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Promissory Note 0001641172-25-010317 1 0 monetary I C Promissory note Promissory note.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001641172-25-010317 2 9 BS 0 H Cash us-gaap/2024 Cash 0
0001641172-25-010317 2 10 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0001641172-25-010317 2 11 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001641172-25-010317 2 13 BS 0 H Property Plant And Equipment Net us-gaap/2024 Machinery and equipment, net 0
0001641172-25-010317 2 14 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating lease right-of-use assets, net 0
0001641172-25-010317 2 15 BS 0 H Other Assets Noncurrent us-gaap/2024 Other noncurrent assets 0
0001641172-25-010317 2 16 BS 0 H Assets us-gaap/2024 TOTAL ASSETS 0
0001641172-25-010317 2 19 BS 0 H Accounts Payable Current us-gaap/2024 Related party accounts payable 0
0001641172-25-010317 2 20 BS 0 H Accrued Liabilities Current us-gaap/2024 Related party accrued expenses and other current liabilities 0
0001641172-25-010317 2 21 BS 0 H Term Notes Payable Current 0001641172-25-010317 Related party term notes payable, net of discount, including accrued interest 0
0001641172-25-010317 2 22 BS 0 H Loans Payable Current us-gaap/2024 Related party bridge loan payable, including accrued interest 0
0001641172-25-010317 2 23 BS 0 H Other Liabilities Current us-gaap/2024 Related party other current liability 0
0001641172-25-010317 2 24 BS 0 H Finance Lease Liability Current us-gaap/2024 Finance lease liability, current 0
0001641172-25-010317 2 25 BS 0 H Operating Lease Liability Current us-gaap/2024 Operating lease right-of-use liability, current 0
0001641172-25-010317 2 26 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001641172-25-010317 2 28 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Operating lease right-of-use liability, noncurrent 0
0001641172-25-010317 2 29 BS 0 H Finance Lease Liability Noncurrent us-gaap/2024 Finance lease liability, noncurrent 0
0001641172-25-010317 2 30 BS 0 H Promissory Note 0001641172-25-010317 Promissory note 0
0001641172-25-010317 2 31 BS 0 H Warrant Liability 0001641172-25-010317 Warrant liability 0
0001641172-25-010317 2 32 BS 0 H Related Party Warrant Liability 0001641172-25-010317 Related party warrant liability 0
0001641172-25-010317 2 33 BS 0 H Liabilities us-gaap/2024 TOTAL LIABILITIES 0
0001641172-25-010317 2 34 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and contingencies (Note 11) 0
0001641172-25-010317 2 36 BS 0 H Common Stock Value us-gaap/2024 Common stock, $0.0001 par value, 330,000 shares authorized; 31,793 and 20,760 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 0
0001641172-25-010317 2 37 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001641172-25-010317 2 38 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive income loss, net of tax 0
0001641172-25-010317 2 39 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001641172-25-010317 2 40 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders equity 0
0001641172-25-010317 2 41 BS 0 H Minority Interest us-gaap/2024 Noncontrolling interest 0
0001641172-25-010317 2 42 BS 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Total equity 0
0001641172-25-010317 2 43 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 TOTAL LIABILITIES AND TOTAL EQUITY 0
0001641172-25-010317 3 1 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value 0
0001641172-25-010317 3 2 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0001641172-25-010317 3 3 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0001641172-25-010317 3 4 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0001641172-25-010317 4 8 IS 0 H Research And Development Expense us-gaap/2024 Research and development 1
0001641172-25-010317 4 9 IS 0 H Selling General And Administrative Expense us-gaap/2024 General and administrative 1
0001641172-25-010317 4 10 IS 0 H Operating Expenses us-gaap/2024 Total operating expense 1
0001641172-25-010317 4 11 IS 0 H Operating Income Loss us-gaap/2024 Loss from operations 0
0001641172-25-010317 4 13 IS 0 H Interest Expense Nonoperating us-gaap/2024 Interest expense 1
0001641172-25-010317 4 14 IS 0 H Change In Fair Value Of Other Liabilities And Derivatives 0001641172-25-010317 Change in fair value of other liabilities and derivatives 1
0001641172-25-010317 4 15 IS 0 H Grant Income 0001641172-25-010317 Grant income 0
0001641172-25-010317 4 16 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other expense, net 0
0001641172-25-010317 4 17 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other income (expenses), net 0
0001641172-25-010317 4 18 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 LOSS BEFORE INCOME TAXES 0
0001641172-25-010317 4 19 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income tax provision 1
0001641172-25-010317 4 20 IS 0 H Profit Loss us-gaap/2024 NET LOSS 0
0001641172-25-010317 4 21 IS 0 H Net Income Loss Attributable To Noncontrolling Interest us-gaap/2024 Net loss attributable to noncontrolling interest 0
0001641172-25-010317 4 22 IS 0 H Net Income Loss Available To Common Stockholders Basic us-gaap/2024 NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS 0
0001641172-25-010317 4 23 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss per share; basic 0
0001641172-25-010317 4 24 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss per share, diluted 0
0001641172-25-010317 4 25 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted average common shares outstanding, basic 0
0001641172-25-010317 4 26 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted average common shares outstanding, diluted 0
0001641172-25-010317 5 1 CI 0 H Net Income Loss us-gaap/2024 NET LOSS 0
0001641172-25-010317 5 3 CI 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation adjustment 0
0001641172-25-010317 5 4 CI 0 H Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2024 COMPREHENSIVE LOSS 0
0001641172-25-010317 5 5 CI 0 H Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2024 Comprehensive loss attributable to noncontrolling interest 0
0001641172-25-010317 5 6 CI 0 H Comprehensive Income Net Of Tax us-gaap/2024 COMPREHENSIVE LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS 0
0001641172-25-010317 6 11 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Balance at December 31, 2023 0
0001641172-25-010317 6 12 EQ 0 H Shares Outstanding us-gaap/2024 Balance, shares 0
0001641172-25-010317 6 13 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Issuance of common stock through At the Market Offering 0
0001641172-25-010317 6 14 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Issuance of common stock through At the Market Offering, shares 0
0001641172-25-010317 6 15 EQ 0 H Issuance Of Common Stock And Warrants Through January Confidentially Marketed Public Offering Net Of Financing Costs 0001641172-25-010317 Issuance of common stock and warrants through January Confidentially Marketed Public Offering, net of financing costs 0
0001641172-25-010317 6 16 EQ 0 H Issuance Of Common Stock And Warrants Through January Confidentially Marketed Public Offering Net Of Financing Costs Shares 0001641172-25-010317 Issuance of common stock and warrants through January Confidentially Marketed Public Offering, net of financing costs, shares 0
0001641172-25-010317 6 17 EQ 0 H Issuance Of Common Stock And Warrants For March Registered Direct Offering And Concurrent Private Placement Net Of Financing Costs 0001641172-25-010317 Issuance of common stock and warrants for March Registered Direct Offering and Concurrent Private Placement, net of financing costs 0
0001641172-25-010317 6 18 EQ 0 H Issuance Of Common Stock And Warrants For March Registered Direct Offering And Concurrent Private Placement Net Of Financing Costs Shares 0001641172-25-010317 Issuance of common stock and warrants for March Registered Direct Offering and Concurrent Private Placement, net of financing costs, shares 0
0001641172-25-010317 6 19 EQ 0 H Stock Issued During Period Value Restricted Stock Award Gross us-gaap/2024 Restricted stock unit shares released 0
0001641172-25-010317 6 20 EQ 0 H Stock Issued During Period Shares Restricted Stock Award Gross us-gaap/2024 Restricted stock unit shares released, shares 0
0001641172-25-010317 6 21 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock-based compensation 0
0001641172-25-010317 6 22 EQ 0 H Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent us-gaap/2024 Foreign currency translation adjustments 0
0001641172-25-010317 6 23 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0001641172-25-010317 6 24 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Balance at March 31, 2024 0
0001641172-25-010317 6 25 EQ 0 H Shares Outstanding us-gaap/2024 Balance, shares 0
0001641172-25-010317 6 26 EQ 0 H Stock Issued During Period Value Issued For Services us-gaap/2024 Issuance of common stock in lieu of cash for services 0
0001641172-25-010317 6 27 EQ 0 H Stock Issued During Period Shares Issued For Services us-gaap/2024 Issuance of common stock in lieu of cash for services, shares 0
0001641172-25-010317 6 28 EQ 0 H Stock Issued During Period Value Lieu Of Cash For Commitment Fee 0001641172-25-010317 Issuance of common stock in lieu of cash for SEPA commitment fee 0
0001641172-25-010317 6 29 EQ 0 H Stock Issued During Period Shares Lieu Of Cash For Commitment Fee 0001641172-25-010317 Issuance of common stock in lieu of cash for commitment fee, shares 0
0001641172-25-010317 6 30 EQ 0 H Stock Issued During Period Value Acquisitions us-gaap/2024 Issuance of common stock to Calidi stockholders as result of Merger 0
0001641172-25-010317 6 31 EQ 0 H Stock Issued During Period Shares Acquisitions us-gaap/2024 Issuance of common stock to Calidi stockholders as result of Merger, shares 0
0001641172-25-010317 6 32 EQ 0 H Adjustments To Additional Paid In Capital Warrant Issued us-gaap/2024 Issuance of warrants for legal settlement 0
0001641172-25-010317 6 33 EQ 0 H Adjustments To Additional Paid In Capital Financing Fees 0001641172-25-010317 Financing fees 0
0001641172-25-010317 7 2 CF 0 H Net Income Loss us-gaap/2024 Net loss 0
0001641172-25-010317 7 4 CF 0 H Depreciation us-gaap/2024 Depreciation expense 0
0001641172-25-010317 7 5 CF 0 H Operating Lease Right Of Use Asset Amortization Expense us-gaap/2024 Amortization of right of use assets 0
0001641172-25-010317 7 6 CF 0 H Amortization Of Debt Discount Premium us-gaap/2024 Amortization of debt discount and financing costs 0
0001641172-25-010317 7 7 CF 0 H Share Based Compensation us-gaap/2024 Stock-based compensation 0
0001641172-25-010317 7 8 CF 0 H Change In Fair Value Of Other Liabilities And Derivatives 0001641172-25-010317 Change in fair value of other liabilities and derivatives 0
0001641172-25-010317 7 10 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0001641172-25-010317 7 11 CF 0 H Increase Decrease In Accounts Payable us-gaap/2024 Accounts payable 0
0001641172-25-010317 7 12 CF 0 H Increase Decrease In Accrued Liabilities And Other Operating Liabilities us-gaap/2024 Accrued expenses and other current liabilities 0
0001641172-25-010317 7 13 CF 0 H Increase Decrease In Operating Lease Liability us-gaap/2024 Operating lease right of use liability 0
0001641172-25-010317 7 14 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0001641172-25-010317 7 16 CF 0 H Payments To Acquire Machinery And Equipment us-gaap/2024 Purchases of machinery and equipment 1
0001641172-25-010317 7 17 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0001641172-25-010317 7 19 CF 0 H Proceeds From April Public Offering 0001641172-25-010317 Proceeds from Public Offerings 0
0001641172-25-010317 7 20 CF 0 H Proceeds From Registered Direct Offering 0001641172-25-010317 Proceeds from Registered Direct Offering 0
0001641172-25-010317 7 21 CF 0 H Repayments Of Related Party Debt us-gaap/2024 Repayment of principal on related party term notes payable 1
0001641172-25-010317 7 22 CF 0 H Repayments Of Notes Payable us-gaap/2024 Repayment of principal on term notes payable 1
0001641172-25-010317 7 23 CF 0 H Repayment Of Principal On Related Party Bridge Loan Payable 0001641172-25-010317 Repayment of principal on related party bridge loan payable 1
0001641172-25-010317 7 24 CF 0 H Repayments Of Debt And Capital Lease Obligations us-gaap/2024 Repayment of financing lease obligations 1
0001641172-25-010317 7 25 CF 0 H Proceeds From Convertible Debt us-gaap/2024 Proceeds from issuance of convertible notes payable 0
0001641172-25-010317 7 26 CF 0 H Proceeds From Related Party Debt us-gaap/2024 Related party proceeds from issuance of loan payable 0
0001641172-25-010317 7 27 CF 0 H Payment Of Interest On Loan Payable 0001641172-25-010317 Payment of interest on loan payable 1
0001641172-25-010317 7 28 CF 0 H Payments Of Financing Costs us-gaap/2024 Payment of financing costs 1
0001641172-25-010317 7 29 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by financing activities 0
0001641172-25-010317 7 30 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Effect of exchange rate changes on cash 0
0001641172-25-010317 7 31 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 NET INCREASE (DECREASE) IN CASH AND RESTRICTED CASH 0
0001641172-25-010317 7 32 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 At beginning of the period 0
0001641172-25-010317 7 33 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 At end of the period 0
0001641172-25-010317 7 35 CF 0 H Interest Paid Net us-gaap/2024 Cash paid for interest 0
0001641172-25-010317 7 36 CF 0 H Income Taxes Paid Net us-gaap/2024 Cash paid for income taxes 0
0001641172-25-010317 7 38 CF 0 H Financing Fees 0001641172-25-010317 Financing fees 0
0001641172-25-010317 7 39 CF 0 H Issuance Of Common Stock In Lieu Of Cash For Services 0001641172-25-010317 Issuance of common stock in lieu of cash for services 0
0001641172-25-010317 7 40 CF 0 H Issuance Of Common Stock In Lieu Of Cash For Sepa Commitment Fee 0001641172-25-010317 Issuance of common stock in lieu of cash for SEPA commitment fee 0
0001641172-25-010317 7 41 CF 0 H Issuance Of Warrants For Legal Settlement 0001641172-25-010317 Issuance of warrants for legal settlement 0
0001641172-25-010317 7 42 CF 0 H Issuance Of Common Stock For Legal Settlement 0001641172-25-010317 Issuance of convertible note for legal settlement 0
0001641172-25-010317 7 43 CF 0 H Discount On Convertible Note Payable 0001641172-25-010317 Discount on convertible note payable 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.